We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Akamai Technologies, Inc. (AKAM - Free Report) : This provider of cloud services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
Akamai’s shares gained 8.3% over the last one month more than S&P 500’s gain of 2.8%. The company possesses a Momentum Score of A.
AcelRx Pharmaceuticals, Inc. : This operator of a specialty pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
Allied Motion Technologies, Inc. : This operator and developer of pipelines and other midstream assets has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.9% over the last 60 days.
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for June 5th
Akamai Technologies, Inc. (AKAM - Free Report) : This provider of cloud services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
Akamai’s shares gained 8.3% over the last one month more than S&P 500’s gain of 2.8%. The company possesses a Momentum Score of A.
Akamai Technologies, Inc. Price and Consensus
Akamai Technologies, Inc. price-consensus-chart | Akamai Technologies, Inc. Quote
AcelRx Pharmaceuticals, Inc. : This operator of a specialty pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
Akamai Technologies, Inc. Price
Akamai Technologies, Inc. price | Akamai Technologies, Inc. Quote
AcelRx’s shares gained 34% over the last one month. The company possesses a Momentum Score of B.
AcelRx Pharmaceuticals, Inc. Price and Consensus
AcelRx Pharmaceuticals, Inc. price-consensus-chart | AcelRx Pharmaceuticals, Inc. Quote
Allied Motion Technologies, Inc. : This operator and developer of pipelines and other midstream assets has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.9% over the last 60 days.
AcelRx Pharmaceuticals, Inc. Price
AcelRx Pharmaceuticals, Inc. price | AcelRx Pharmaceuticals, Inc. Quote
Allied Motion’s shares gained 4.2% over the last one month. The company possesses a Momentum Score of B.
Allied Motion Technologies, Inc. Price and Consensus
Allied Motion Technologies, Inc. price-consensus-chart | Allied Motion Technologies, Inc. Quote
Allied Motion Technologies, Inc. Price
Allied Motion Technologies, Inc. price | Allied Motion Technologies, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>